Health-related quality of life in patients with chronic fatigue syndrome: an international study.
Hardt, J, Buchwald, D, Wilks, D et al. · Journal of psychosomatic research · 2001 · DOI
Quick Summary
This study measured how ME/CFS affects daily life and well-being in patients from the United States, United Kingdom, and Germany. Researchers found that patients in all three countries experienced very similar impacts on their quality of life—significantly worse than healthy people across most areas measured, including physical function, emotional health, and energy levels. The findings suggest that ME/CFS affects people similarly regardless of where they live.
Why It Matters
This is one of the first international studies showing that ME/CFS causes consistent and severe impacts on quality of life across different healthcare systems and populations. This finding validates the global burden of the disease and suggests that underlying disease mechanisms may be similar worldwide, which is important for developing treatments that could help patients everywhere.
Observed Findings
CFS patients in the US, UK, and Germany showed remarkably similar profiles of health-related quality of life impairment.
Patients scored 2-3 standard deviations below healthy population norms on six of eight SF-36 subscales.
Patients scored 1 standard deviation below normal on the remaining two subscales.
Factor analysis revealed a two-factor model with six subscales loading on the first factor and two on the second factor across all countries.
The similarity in HRQoL patterns held consistent despite geographical, healthcare system, and cultural differences.
Inferred Conclusions
Health-related quality of life is severely and uniformly impaired in CFS patients internationally, suggesting a consistent disease phenotype across different populations.
The two-factor structure of HRQoL impairment may reflect distinct pathophysiological domains of the disease.
CFS affects multiple dimensions of life quality similarly across countries, indicating the disease's global importance and potential common underlying mechanisms.
Remaining Questions
What biological or environmental factors explain why CFS impairs quality of life in these particular domains?
How does quality of life change over time, and are there subgroups of patients with better or worse trajectories?
What This Study Does Not Prove
This study does not establish what causes the poor quality of life in ME/CFS patients or whether biological differences exist between patients in different countries. It also cannot explain why quality of life is impaired in these specific ways, nor does it track how quality of life changes over time or in response to treatments.